Free Trial

Aardvark Therapeutics (AARD) Institutional Ownership

Aardvark Therapeutics logo
$4.54 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$4.72 +0.19 (+4.07%)
As of 05/22/2026 07:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Aardvark Therapeutics (NASDAQ:AARD)

Number of
Institutional Buyers
(last 12 months)
36
Total
Institutional Inflows
(last 12 months)
$29.45M
Number of
Institutional Sellers
(last 12 months)
7
Total
Institutional Outflows
(last 12 months)
$4.92M
Get AARD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aardvark Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

AARD Institutional Buying and Selling by Quarter

Aardvark Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026 Bank of America Corp DE11,486$43K0.0%-62.5%0.053%
5/14/2026 Renaissance Technologies LLC70,792$267K0.0%N/A0.324%
5/5/2026 Bank of New York Mellon Corp29,320$111K0.0%+30.8%0.134%
2/18/2026 XTX Topco Ltd25,548$335K0.0%N/A0.117%
2/18/2026 Superstring Capital Management LP69,496$912K0.5%N/A0.319%
2/18/2026 Millennium Management LLC483,340$6.34M0.0%+51.2%2.220%
2/18/2026 Balyasny Asset Management L.P.13,817$181K0.0%N/A0.063%
2/18/2026 Bridgeway Capital Management LLC27,000$354K0.0%+22.7%0.124%
2/17/2026 Schonfeld Strategic Advisors LLC50,131$658K0.0%-80.2%0.230%
2/17/2026 Cantor Fitzgerald L. P.91,682$1.20M0.0%-5.2%0.421%
2/17/2026 Trexquant Investment LP16,844$221K0.0%N/A0.077%
2/17/2026 Jump Financial LLC34,575$454K0.0%N/A0.159%
2/17/2026 Laurion Capital Management LP1,014,911$13.32M0.5%-3.3%4.662%
2/17/2026 Diadema Partners LP15,882$208K0.0%N/A0.073%
2/17/2026 Persistent Asset Partners Ltd4,231$56K0.0%N/A0.019%
2/16/2026 Barclays PLC20,516$269K0.0%-48.6%0.094%
2/13/2026 Walleye Capital LLC16,048$211K0.0%N/A0.074%
2/13/2026 Charles Schwab Investment Management Inc.31,533$414K0.0%+121.4%0.145%
2/13/2026 State Street Corp158,240$2.08M0.0%+70.1%0.727%
2/13/2026 Wells Fargo & Company MN14,080$185K0.0%+259.5%0.065%
2/12/2026 HRT Financial LP31,066$407K0.0%N/A0.143%
2/12/2026 MetLife Investment Management LLC7,750$102K0.0%N/A0.036%
2/12/2026 SymBiosis Capital Partners LLC476,595$6.26M6.0%N/A2.189%
2/12/2026 Alps Advisors Inc.17,877$235K0.0%N/A0.082%
2/12/2026 Nuveen LLC41,022$538K0.0%N/A0.188%
2/11/2026 Los Angeles Capital Management LLC20,837$273K0.0%N/A0.096%
2/11/2026 Propel Bio Management LLC46,408$609K0.5%N/A0.213%
2/10/2026 Goldman Sachs Group Inc.53,349$700K0.0%+181.9%0.245%
2/9/2026 Geode Capital Management LLC297,865$3.91M0.0%+53.5%1.368%
1/29/2026 China Universal Asset Management Co. Ltd.3,548$47K0.0%N/A0.016%
12/1/2025 Cantor Fitzgerald L. P.96,682$1.29M0.0%+26.1%0.444%
11/17/2025 Laurion Capital Management LP1,049,721$13.95M0.2%+6.1%4.838%
11/17/2025 Millennium Management LLC319,623$4.25M0.0%N/A1.473%
11/17/2025 Citadel Advisors LLC1,359,883$18.07M0.0%+5.9%6.268%
11/17/2025 Bank of America Corp DE23,930$318K0.0%+199.5%0.110%
11/17/2025 Cantor Fitzgerald L. P.96,682$1.29M0.0%+26.1%0.446%
11/14/2025 Schonfeld Strategic Advisors LLC253,752$3.37M0.0%-9.1%1.169%
11/14/2025 Two Sigma Investments LP63,569$845K0.0%N/A0.293%
11/14/2025 Bridgeway Capital Management LLC22,000$292K0.0%N/A0.101%
11/13/2025 UBS Group AG54,728$727K0.0%+5.4%0.252%
Porter flew 3,300 miles to investigate this system (Ad)

Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel

Watch the full investigation and decide for yourself
11/13/2025 BNP Paribas Financial Markets56,546$751K0.0%+59.3%0.261%
11/12/2025 Cresset Asset Management LLC146,783$1.95M0.0%N/A0.676%
11/7/2025Vanguard Group Inc.555,721$7.39M0.0%+20.6%2.561%
11/3/2025 New York State Common Retirement Fund3,823$51K0.0%-47.6%0.018%
8/15/2025 Bank of America Corp DE7,989$108K0.0%+72.9%0.037%
8/15/2025 Adage Capital Partners GP L.L.C.175,000$2.37M0.0%-30.0%0.806%
8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.3,091$42K0.0%N/A0.014%
8/13/2025 New York State Common Retirement Fund7,300$99K0.0%N/A0.034%
8/8/2025 Geode Capital Management LLC136,927$1.85M0.0%+129.7%0.631%
6/27/2025 Goldman Sachs Group Inc.20,311$153K0.0%N/A0.094%
5/16/2025Goldman Sachs Group Inc.20,311$153K0.0%N/A0.094%
5/16/2025Cormorant Asset Management LP800,189$6.01M0.5%N/A3.688%
5/16/2025Adage Capital Partners GP L.L.C.250,000$1.88M0.0%N/A1.152%
5/15/2025Braidwell LP500,000$3.76M0.1%N/A2.305%
5/14/2025Walleye Capital LLC11,730$88K0.0%N/A0.054%
5/8/2025Decheng Capital LLC3,917,299$29.42M8.3%N/A18.055%


AARD Institutional Ownership - Frequently Asked Questions

During the previous two years, 42 institutional investors and hedge funds held shares of Aardvark Therapeutics. The most heavily invested institutionals were Decheng Capital LLC ($29.42M), Citadel Advisors LLC ($18.07M), Laurion Capital Management LP ($13.32M), Vanguard Group Inc. ($7.39M), Millennium Management LLC ($6.34M), SymBiosis Capital Partners LLC ($6.26M), and Cormorant Asset Management LP ($6.01M).Learn more on Aardvark Therapeutics' institutional investors.

Of the 40 institutional investors that purchased Aardvark Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Decheng Capital LLC ($3.92M), Cormorant Asset Management LP ($800.19K), Braidwell LP ($500K), Millennium Management LLC ($483.34K), SymBiosis Capital Partners LLC ($476.60K), Adage Capital Partners GP L.L.C. ($250K), and Geode Capital Management LLC ($181.16K).

Institutional investors have bought a total of 2,293,619 shares in the last 24 months. This purchase volume represents approximately $29.45M in transactions.

The following institutional investors have sold Aardvark Therapeutics stock in the last 24 months: Schonfeld Strategic Advisors LLC ($229.13K), Adage Capital Partners GP L.L.C. ($75K), Laurion Capital Management LP ($34.81K), Barclays PLC ($19.41K), Bank of America Corp DE ($19.17K), Cantor Fitzgerald L. P. ($5K), and New York State Common Retirement Fund ($3.48K).

Institutional investors have sold a total of 385,998 shares in the last 24 months. This volume of shares sold represents approximately $4.92M in transactions.



This page (NASDAQ:AARD) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners